Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 May 1;141(5):1004-1006.
doi: 10.1097/AOG.0000000000005147. Epub 2023 Apr 5.

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Affiliations
Free article
Clinical Trial

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Beatrice A Chen et al. Obstet Gynecol. .
Free article

Abstract

Funding source: Medicines360. The Sponsor, Medicines360, designed the study and oversaw its conduct, including funding the trial and providing all study product free of charge to participants.

Clinical trial registration: ClinicalTrials.gov, NCT00995150.

PubMed Disclaimer

References

    1. Creinin MD, Schreiber CA, Turok DK, Cwiak C, Chen BA, Olariu AI. Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. Am J Obstet Gynecol 2022;227:871.e1–7. doi: 10.1016/j.ajog.2022.05.022 - DOI
    1. Jensen JT, Lukkari-Lax E, Schulze A, Wahdan Y, Serrani M, Kroll R. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial. Am J Obstet Gynecol 2022;227:873.e1–12. doi: 10.1016/j.ajog.2022.09.007 - DOI
    1. Eisenberg DL, Schreiber CA, Turok DK, Teal SB, Westhoff CL, Creinin MD, et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception 2015;92:10–6. doi: 10.1016/j.contraception.2015.04.006 - DOI
    1. Teal SB, Turok DK, Chen BA, Kimble T, Olariu AI, Creinin MD. Five-year contraceptive efficacy and safety of a levonorgestrel 52-mg intrauterine system. Obstet Gynecol 2019;133:63–70. doi: 10.1097/AOG.0000000000003034 - DOI
    1. Liletta prescribing information. Accessed February 6, 2023. https://www.rxabbvie.com/pdf/liletta_pi.pdf

Publication types

Substances

Associated data